Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HNO International (HNOI) Research & Development (2022 - 2024)

HNO International's Research & Development history spans 3 years, with the latest figure at $5901.0 for Q1 2024.

  • For the quarter ending Q1 2024, Research & Development rose 6384.62% year-over-year to $5901.0, compared with a TTM value of $45132.0 through Jan 2024, changed N/A, and an annual FY2023 reading of $43049.0, down 18.65% over the prior year.
  • Research & Development for Q1 2024 was $5901.0 at HNO International, down from $24138.0 in the prior quarter.
  • The five-year high for Research & Development was $24138.0 in Q4 2023, with the low at $91.0 in Q1 2023.
  • Average Research & Development over 3 years is $10865.3, with a median of $10451.5 recorded in 2023.
  • Year-over-year, Research & Development fell 12.41% in 2023 and then skyrocketed 6384.62% in 2024.
  • Tracing HNOI's Research & Development over 3 years: stood at $2933.0 in 2022, then surged by 722.98% to $24138.0 in 2023, then tumbled by 75.55% to $5901.0 in 2024.
  • Per Business Quant, the three most recent readings for HNOI's Research & Development are $5901.0 (Q1 2024), $24138.0 (Q4 2023), and $15002.0 (Q3 2023).